These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 8793314)

  • 1. Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.
    Pani PP; Pirastu R; Ricci A; Gessa GL
    Drug Alcohol Depend; 1996 May; 41(1):81-4. PubMed ID: 8793314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retention in a low-threshold methadone maintenance program.
    Torrens M; Castillo C; Pérez-Solá V
    Drug Alcohol Depend; 1996 May; 41(1):55-9. PubMed ID: 8793310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Client variables associated with selection and outcome in a methadone tapering program.
    Capone CT; Haggerty EL; Acer K; Melchionda R; Holley E; Adams H; Logan F
    Int J Addict; 1994 Feb; 29(3):387-94. PubMed ID: 8188434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Retention in treatment of heroin users in Italy: the role of treatment type and of methadone maintenance dosage.
    D'Ippoliti D; Davoli M; Perucci CA; Pasqualini F; Bargagli AM
    Drug Alcohol Depend; 1998 Oct; 52(2):167-71. PubMed ID: 9800146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life among heroin users on buprenorphine versus methadone maintenance.
    Ponizovsky AM; Grinshpoon A
    Am J Drug Alcohol Abuse; 2007; 33(5):631-42. PubMed ID: 17891656
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supervised daily consumption, contingent take-home incentive and non-contingent take-home in methadone maintenance.
    Gerra G; Saenz E; Busse A; Maremmani I; Ciccocioppo R; Zaimovic A; Gerra ML; Amore M; Manfredini M; Donnini C; Somaini L
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):483-9. PubMed ID: 21147192
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent developments in maintenance prescribing and monitoring in the United Kingdom.
    Brewer C
    Bull N Y Acad Med; 1995; 72(2):359-70. PubMed ID: 10101376
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dosage regimes in the prescription of heroin and other narcotics to chronic opioid addicts in Switzerland--Swiss national cohort study.
    Gschwend P; Rehm J; Blättler R; Steffen T; Seidenberg A; Christen S; Bürki C; Gutzwiller F
    Eur Addict Res; 2004; 10(1):41-8. PubMed ID: 14665805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Contingent methadone take-home doses reinforce adjunct therapy attendance of methadone maintenance patients.
    Kidorf M; Stitzer ML; Brooner RK; Goldberg J
    Drug Alcohol Depend; 1994 Dec; 36(3):221-6. PubMed ID: 7889813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduced drug craving and better social function with buprenorphine therapy. Combination therapy as an alternative to methadone therapy in heroin addiction].
    Heilig M; Kakko J
    Lakartidningen; 2003 Aug; 100(32-33):2526-7. PubMed ID: 12959012
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled use of heroin in patients on methadone maintenance treatment.
    Bianchi E; Maremmani I; Meloni D; Tagliamonte A
    J Subst Abuse Treat; 1992; 9(4):383-7. PubMed ID: 1479633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term methadone maintenance effectiveness: psychosocial and pharmacological variables.
    Gerra G; Ferri M; Polidori E; Santoro G; Zaimovic A; Sternieri E
    J Subst Abuse Treat; 2003 Jul; 25(1):1-8. PubMed ID: 14512102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Self-reported cravings for heroin and cocaine during maintenance treatment with slow-release oral morphine compared with methadone: a randomized, crossover clinical trial.
    Falcato L; Beck T; Reimer J; Verthein U
    J Clin Psychopharmacol; 2015 Apr; 35(2):150-7. PubMed ID: 25679130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Relations between the care recipients and nurses. Auto-efficiency or urgency of resources].
    Quiénot C
    Krankenpfl Soins Infirm; 2003; 96(11):48-51. PubMed ID: 14669478
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of a new drug in the treatment of heroin addicts should not be obstructed by political dogmatism].
    Heilig M; Nilsson LH; Grönbladh L; Thulin SO; Sternebring B
    Lakartidningen; 2001 Sep; 98(37):3956-8. PubMed ID: 11586837
    [No Abstract]   [Full Text] [Related]  

  • 16. [Frequency of injection of oral methadone solutions at treatment center for opiate dependence].
    Waldvogel D; Uehlinger C
    Fortschr Neurol Psychiatr; 1999 Jun; 67(6):281-3. PubMed ID: 10399048
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Methadone and naltrexone in heroin addiction--an explanation from the SBU].
    Asplund K; Jonsson E
    Lakartidningen; 2002 Feb; 99(6):552-3. PubMed ID: 11881233
    [No Abstract]   [Full Text] [Related]  

  • 18. Methadone applicant dropouts: impact of requiring involvement of friends or family in treatment.
    Sorensen JL; Gibson D; Bernal G; Deitch D
    Int J Addict; 1985 Aug; 20(8):1273-80. PubMed ID: 4077323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosocial correlates of retention in methadone maintenance.
    Steer RA
    Int J Addict; 1980 Oct; 15(7):1003-9. PubMed ID: 7450944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Earning "take-home" privileges and long-term outcome in a methadone maintenance treatment program.
    Peles E; Schreiber S; Sason A; Adelson M
    J Addict Med; 2011 Jun; 5(2):92-8. PubMed ID: 21769054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.